# Thiotepa

NDC: 65219-029
Generic name: Thiotepa
Labeler / Manufacturer: Fresenius Kabi USA, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: INTRACAVITARY, INTRAVENOUS, INTRAVESICAL
Marketing started: 20220411

FDA application: ANDA214222

## Active ingredients

- THIOTEPA: 100 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"65219-029"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=65219-029
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=493410f3-0733-4f76-8050-6529d96f2a5b